Effective Nutritional Support for Menstrual & PMS Symptoms and Hormonal Fluctuations Contributing to Migraines
Physicians who specialize in female related health issues have discovered two critical insights: (1) there is a direct relationship between changes in the levels of female hormones and migraines, and that fluctuations in hormones and blood sugar levels are both major factors, and (2) migraines beget migraines—the more you have the more you will tend to get. The suspicion is that the brain goes into a state of hypersensitivity, which makes averting an event an important response strategy.
This is why MigreLief+M was researched and developed as an effective combination of 8 key ingredients shown in human clinical studies to balance blood sugar levels and hormones most necessary during monthly menstruation, the reproductive years, perimenopause and menopause when women are most likely susceptible to migraines.*
The MigreLief+M formula defends women from experiencing the following hormone related symptoms:
Irregular menstrual cycles
MigreLief+M is a targeted formula containing clinically recommended amounts of riboflavin (vitamin B-2), magnesium, pyridoxine hydrochloride (vitamin B-6), biotin, Puracol®, chasteberry extract, l-theanine, chromium. By combining all 8 ingredients into one convenient formula, MigreLief+M provides comprehensive, synergistic nutritional support for female issues related to menstrual and hormonal imbalances.*
[Read more in the “Ingredients” tab.]
As with all Akeso products, MigreLief was developed with an expert understanding of the profound link between human biology and the chemistry found in nature. The success of MigreLief is greatly attributed to the scientific research that Akeso Health Sciences performs to ensure the effective combination of ingredients, to provide clinically recognized amounts, and to make certain that the extraction processes used do not cause degradation to occur during the life of the product.
MigreLief+M continues to be recommended by healthcare professionals, and our customers recognize MigreLief+M as the clear choice because …
MigreLief+M is based on the only original patented material successfully used by hundreds of thousands of customers worldwide for more than 20 years
MigreLief+M is recommended by female and headache specialists
MigreLief+M is safe & effective for daily use—non-prescription and drug free
MigreLief+Mdoes not contain butterbur, wheat, gluten, salt, soy, milk or dairy, nuts, corn, caffeine, or artificial flavorings or preservatives. Non-GMO. Vegan.
MigreLief+M was researched and developed by Akeso Health Sciences Chief Scientific Officer, Curt Hendrix, who holds advanced degrees in chemistry and clinical nutrition and has dedicated his life to providing innovative natural medicines
MigreLief+M is manufactured in an established GMP facility
MigreLief+M maintains an effective track record with 3rd-party batch testing on every product by a top, industry-focused lab under the guidance of a forensic expert, in business over 30 years
*This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
MigreLief® - Original Patented Formula with Puracol®
60 Caplets / 2 per day / 1-month supply
MigreLief+M IS A TRUSTED FORMULA THAT MAKES A DIFFERENCE – Our MigreLief® line of products has changed lives worldwide by providing effective nutritional support to migraine sufferers.
Amount per day
Riboflavin (Vitamin B-2)
Magnesium (citrate and oxide)
Pyridoxine Hydrochloride (Vitamin B-6)
Biotin (biotin-d, 15,000mcg)
Puracol® Feverfew** (Tanacetum parthenium)
*No Daily Value established
**Puracol® is a proprietary combination of whole leaf feverfew that is high in naturally occurring phytochemicals and a special feverfew extract high in parthenolides, key to health benefits.
Puracol®—a proprietary blend of whole leaf and carefully guarded extraction of Feverfew [featuring parthenolide and other naturally occurring plant phytochemicals]
Riboflavin—high doses of Riboflavin have been proven in clinical studies to reduce the number of neurological discomforts experienced each month and improve mitochondrial energy deficiencies
Magnesium—two clinically known beneficial forms critical to controlling the inhibition of vasospasm
Chasteberry Extract—has been shown in numerous studies to establish balance of female hormones, and reduce discomfort, excessive bleeding, and signs of PMS and POCS
L-Theanine—L-theanine is an amino acid known to calm without making you drowsy, increase alpha wave activity in the brain, and lessens signs of PMS.
D-Biotin—higher amounts of biotin is required to stabilize blood sugar levels, which is strongly related to the occurrence of migraines, and the symptoms of PMS and PCOS
Pyridoxine Hydrochloride (vitamin B-6)—Multiple human studies (listed below) in almost 1000 women, have shown that vitamin B-6 helps to alleviate PMS symptoms of breast pain, irritability, depression, cravings and bloating.
Chromium—an essential trace mineral that can improve insulin sensitivity and enhance protein, carbohydrate, and lipid metabolism
MigreLief+M is intended for use by menstruating females, or pre-menopausal/menopausal women who suffer from chronic migraines associated with their periods or menopause and/or symptoms of PMS and symptoms of PCOS.
Take one caplet twice a day for 90 days during the build-up period. To maintain benefits, continue daily use. For as-needed additional support and comfort, try adding MigreLief-NOWfollowing recommended use directions for that product.
Caution: Not recommended for use during pregnancy, during lactation, or for young females prior to menstruation.
Riboflavin (Vitamin B-2) can cause urine to become bright yellow. This is normal and harmless.
Although rare, some individuals experience transient (short term) diarrhea when taking magnesium.
Like most dietary supplements, use of MigreLief+M should be discontinued one week before any surgery.
Brown D, Gaby A, Reichert R. Clinical Applications of Natural Medicine–Migraine. NPRC Condition-Specific Monograph Series, 1997.
Lawrence Review of Natural Products, September 1994.
Awang DVC. Herbal Medicine, Feverfew. Canadian Pharm J 1989; 122:266-70.
Heptinstall S, Awang DVC, Dawson BA, et al. Parthenolide Content and Bioactivity of Feverfew (Tanacetum parthenium). Estimation of Commercial and Authenticated Feverfew Products. J Pharm Pharmacol 1992; 44:391-5.
Pugh WJ, Sambo K. Prostaglandin Synthetase Inhibitors in Feverfew. J Pharm Pharmacol 1988; 40-743-5.
Heptinstall S, White A, Williamson L, Mitchell JRA. Extracts of Feverfew Inhibit Granule Secretion in Blood Platelets and Polymophonuclear Leukocytes. Lancet 1985; i:1071-4.
Makheja AN, Bailey JM. A Platelet Phospholipase Inhibitor from the Medicinal Herb Feverfew (Tanacetum parthenium). Prostagland Leukotrienes Med 1982;8:653-60.
Sumner H, Salan U, Knight DW, Hoult JRS. Inhibition of 5-Lipoxygenase and Cyclo-oxygenase in Leukocytes by Feverfew. Biochem Pharmacol 1992;43:2313-20.
Johnson ES, Kadam NP, Hylands DM, Hylands PF. Efficacy of Feverfew As prophylactic Treatment of Migraine. British Med J 1985; 291:569-73.
Murphy JJ. Heptinstall S, Mitchell JRA. Randomized Double-Blind Placebo-Controlled Trial of Feverfew in Migraine Prevention. Lancet 1988; ii:189-92.
Altura BM. Calcium Antagonist Properties of Magnesium: Implications for Anti-migraine Actions. Magnesium 1985; 4:169-75.
Ramadan NM, Halvorson H, Vande-Linde A, et al. Low Brain Magnesium in Migraine. Headache 1989; 29:590-93.
Weaver K. Magnesium and Migraine. Headache 1990; 30:168.
Faccinetti F, Sances G, Borella P, et al. Magnesium Prophylaxis of Menstrual Migraine: Effects on Intra-cellular Magnesium. Headache 1991; 31:298-304.
Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of Migraine with Oral Magnesium: Results from a Prospective, Multi-Center, Placebo-Controlled and Double-Blind Randomized Study. Cephalalgia 1996; 16:257-63.
Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the Prophylaxis of Migraine–A Double-Blind, Placebo-Controlled Study. Cephalalgia 1996;16:436-40.
Schoenen J, Lenaerts M, Bastings E. High-dose Riboflavin as a Prophylactic Treatment of Migraine: Results of an Open Pilot Study. Cephalalgia 1994l14:328-9
Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomised controlled trial. Neurology 1998; 50: 46670.
Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004 Jul;11(7):475-7.
Maria Condò1, Annio Posar1, Annalisa Arbizzani1 and Antonia Parmeggiani1 Riboflavin prophylaxis in pediatric and adolescent migraine. The Journal of Headache and Pain: Volume 10, Number 5 / October, 2009
Schellenberg R. Treatment for PMS with agnus castus. BMJ. 2001 Han 20;322(7279):134-7
Haut-und Gesch. 1964; 36:220 Giss, G. Rothenburg,W.
Ggw 1967;106:124-6 Amann W. Improvement of acne vulgaris with Agnus castus
Zbl GynSkol 1959 81:701 Bleier, W.
Medica Emperica 1990, 9”494-502 Bohnert, K.J. Hahs, G. Phytotherapy in Gynecology and Obstetrics (Chasteberry) Acta
clin. Biochem Nutr. 1993;14:211-218 Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin dependent diabetes mellitus.
2007 Nov-Dec;47(10):1436-43 Insulin metabolism is altered in migraineurs. Cavestro, C. et al
J Obstet Gynaecol 1990;97:847-52 vitamin B6 in the treatment of the premenstrual syndrome- a review, Kleijnen J. Riet GT et al
Int J]. Gunn AD Vitam Nutr Res. 1985;Suppl 27:213–24 review
J Int Med Res 1985;13:174-9 Controlled trial of B6 in PMS Harris RI, Deand BC
Lancet 1985;1399 B6 and PMS Brush MG, Perry M.
BMJ 1999;318;1375-81 Systematic Review B6 and PMS Dimmock PW et al
Arch Dermatol 1974;110:130-131 B6 for premenstrual acne Snider B et al
J Invest Dermatol 1942;5:143-8 B6 on resistant adolescent acne. Joliffe N et al
Clin Neuropharmacol 30(1):25-38 Electrical mapping of the effect of theanine. Higgin BA et al
Bio Psychol 74(1):39-45 Theanine reduces psychological and physiological stress Ozeki M et al.
Biol Psychol 77(2):113-22 Effects of theanine and caffeine on cognition and mood Kimura k et al.